About Apolipoprotein L3
Apolipoprotein L3 (APOL3) is a protein
from Homo sapiens identified by UniProt accession
O95236, 402 residues long.
MolForge cross-references it against 0 known binders and
38 disease associations.
Target properties
| Protein name | Apolipoprotein L3 |
| UniProt accession | O95236 |
| Gene | APOL3 |
| Organism | Homo sapiens |
| Length | 402 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (38)
Diseases linked to this target (Open Targets).
- serum alanine aminotransferase measurement · score 0.45
- aspartate aminotransferase measurement · score 0.43
- alkaline phosphatase measurement · score 0.43
- glomerular filtration rate · score 0.41
- leukocyte count · score 0.39
- creatinine measurement · score 0.37
- aspartate aminotransferase to alanine aminotransferase ratio · score 0.30
- total blood protein measurement · score 0.30
- hematocrit · score 0.20
- lymphocyte count · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95236-F1 | alphafold | PREDICTED | 59.32 | — |
Amino-acid sequence (402 residues)
MGLGQGWGWE ASCFACLIRS CCQVVTFTFP FGFQGISQSL ENVSGYYADA RLEVGSTQLR TAGSCSHSFK RSFLEKKRFT EEATKYFRER VSPVHLQILL TNNEAWKRFV TAAELPRDEA DALYEALKKL RTYAAIEDEY VQQKDEQFRE WFLKEFPQVK RKIQESIEKL RALANGIEEV HRGCTISNVV SSSTGAASGI MSLAGLVLAP FTAGTSLALT AAGVGLGAAS AVTGITTSIV EHSYTSSAEA EASRLTATSI DRLKVFKEVM RDITPNLLSL LNNYYEATQT IGSEIRAIRQ ARARARLPVT TWRISAGSGG QAERTIAGTT RAVSRGARIL SATTSGIFLA LDVVNLVYES KHLHEGAKSA SAEELRRQAQ ELEENLMELT QIYQRLNPCH TH
Explore Apolipoprotein L3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets